Lack of seasonal variability of blood eosinophil counts in COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018
Characterisation of UK and US COPD populations in reference to exacerbation frequency and blood eosinophils level Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018
High eosinophil counts predict decline in FEV1 : results from the CanCOLD study Source: Eur Respir J, 57 (5) 2000838; 10.1183/13993003.00838-2020 Year: 2021
Blood eosinophil counts and degree of allergen sensitization as age dependent correlations in children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 452s Year: 2001
Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003
Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Mycoplasma pneumoniae infection affects total eosinophil count, the serum level of ECP, and interleukin-5 in atopic childrenSource: Annual Congress 2012 - Airway infections in children: from risk factors to treatment Year: 2012
Relationship between blood eosinophil count and bronchial epithelial gene expression in COPD versus Asthma Source: International Congress 2018 – Eosinophils in airway disease Year: 2018
Asthma and chronic rhinosinusitis: comparative evaluation of IgE plasma level, CD23+ and blood eosinophils Source: International Congress 2017 – Bronchial asthma management Year: 2017
Stability of blood eosinophils over time in patients with asthma Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015